← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 1996First marketed drug
Sep 25, 1998First NDA
Sep 25, 1998Last known activity
Nov 1, 1998
Defunct as of Jun 1, 1995
Timeline
1980s
- Jan 1, 1985
Anthra Pharmaceuticals— Founded
1990s
- Jun 1, 1995
Anthra Pharmaceuticals— Defunct
- Sep 25, 1998
valrubicin— NDA Organization
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Approved for
Studied for
Marketed drugs (1)
Recent trials (2)
- NCT00003759Lead sponsorPhase 2Nov 1, 1998
- NCT00003725Lead sponsorPhase 3Dec 1, 1996
Details
- Founded
- Princeton, NJ, US Jan 1, 1985
- First NDA
- Sep 25, 1998
- Last known activity
- Nov 1, 1998
Designations held
- Orphan drug
- Priority review